Fresenius Medical Care AG & Co. KGaA Financials

Market Capitalization €11.79 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	16.70
Forward PE	9.78
Price to Sales TTM	€0.61
Price to Book MRQ	€0.91
Enterprise to Revenue	1.12
Enterprise to EBITDA	8.97

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-09-30
Profit Margin	3.66%
Operating Margin	10.27%
Return on Assets TTM	3.33%
Return on Equity TTM	6.32%

Income Statement

Revenue TTM	€19,642,804,224
Revenue per Share TTM	€67.02
Quarterly Revenue Growth	2.60%
Gross Profit TTM	€4,910,985,216
EBITDA	€2,868,277,000
Net Income to Common TTM	€718,188,032
Diluted EPS TTM	€2.44
Quarterly Earnings Growth YoY	29.00%

Balance Sheet

Total Cash MRQ	€1,255,948,032
Total Cash per Share MRQ	€4.33
Total Debt MRQ	€
Total Debt to Equity MRQ	75.36
Current Ratio MRQ	1.36
Book Value per Share MRQ	€44.67

Cash Flow

Operating Cash Flow TTM	€2,511,014,912
Levered Free Cash Flow TTM	€2,148,724,992

FME Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	289,848,926
Float Shares	203,653,652
Avg 10 Volume	735,385
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	28.55%
% Held by Institutions	43.91%

Stock Price Summary

Beta	0.95
Fifty Two Week Low	€38.98
Fifty Two Week High	€54.02
Fifty Two Week Change	-10.28%
Day 50 MA	€41.71
Day 200 MA	€44.76

Dividends and Splits

Forward Annual Dividend Rate	€5.76
Forward Annual Dividend Yield	14.34%
Trailing Annual Dividend Rate	€1.44
Trailing Annual Dividend Yield	3.58%
Payout Ratio	59.02%
Dividend Date
Ex Dividend Date	2025-05-23
Last Split Factor
Last Split Date	2007-06-18